Evidence map›Paper›PMID 42632983›Full record

ArticleClinical case reports2026

Remimazolam for Zephyr Endobronchial Valve Placement in a Severe Chronic Obstructive Pulmonary Disease Patient: A Case Report.

Takayuki Morimoto, Taiga Ichinomiya, Shohei Tobinaga, Shohei Kaneko, Motohiro Sekino, Hiroaki Murata, Susumu Fukahori, Tetsuya Hara

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Takayuki MorimotoDepartment of Anesthesiology and Intensive Care Medicine Nagasaki University Graduate School of Biomedical Sciences Nagasaki Japan.ORCID https://orcid.org/0009-0004-5284-961X
Taiga IchinomiyaDepartment of Anesthesiology and Intensive Care Medicine Nagasaki University Graduate School of Biomedical Sciences Nagasaki Japan.
Shohei TobinagaDepartment of Anesthesiology and Intensive Care Medicine Nagasaki University Graduate School of Biomedical Sciences Nagasaki Japan.
Shohei KanekoDepartment of Anesthesiology and Intensive Care Medicine Nagasaki University Graduate School of Biomedical Sciences Nagasaki Japan.
Motohiro SekinoDepartment of Anesthesiology and Intensive Care Medicine Nagasaki University Graduate School of Biomedical Sciences Nagasaki Japan.
Hiroaki MurataDepartment of Anesthesiology and Intensive Care Medicine Nagasaki University Graduate School of Biomedical Sciences Nagasaki Japan.
Susumu FukahoriDepartment of Respiratory Medicine Nagasaki University Graduate School of Biomedical Sciences Nagasaki Japan.
Tetsuya HaraDepartment of Anesthesiology and Intensive Care Medicine Nagasaki University Graduate School of Biomedical Sciences Nagasaki Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Remimazolam-based general anesthesia provided stable hemodynamics and rapid, clear emergence in a patient with severe chronic obstructive pulmonary disease undergoing Zephyr endobronchial valve placement, suggesting that remimazolam may be a feasible anesthetic option for this procedure in patients with limited cardiopulmonary reserve.

Indexed as

bronchoscopic lung volume reductionchronic obstructive pulmonary diseasegeneral anesthesiapropofolremimazolamZephyr endobronchial valve placement

Identifiers

PMID42632983
PMCPMC13498759

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.